SER-224

N/A

Report date: 2025/01/26 17:05:06
NME

Base Information

Drug NameSER-224
Drug Alias NameTRPV1 antagonist (Serentrix)SER-224
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVanilloid receptor antagonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSerentrix LLC
China Registration ClassN/A

Develop Information

Active CompaniesSerentrix LLC
Inactive CompaniesN/A
Active IndicationsIrritable Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A